Drug Profile
R 1487
Alternative Names: R1487Latest Information Update: 12 May 2004
Price :
$50
*
At a glance
- Originator Roche
- Class Antirheumatics
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 12 May 2004 Discontinued - Phase-I for Rheumatoid arthritis in Europe (unspecified route)
- 22 Nov 2002 Phase-I clinical trials in Rheumatoid arthritis in Europe (unspecified route)
- 11 Apr 2002 Preclinical trials in Rheumatoid arthritis in Europe (unspecified route)